Trial Profile
Randomised, Prospective Multicentre Clinical Study on the Effect of the Combination of Lopinavir/Rtv + Nevirapine as Maintenance Bitherapy (Without Nucleoside Analogues) in Comparison With a Triple Therapy Including Lopinavir/Rtv + Nucleoside Analogues in HIV-Infected Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2020
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Nevirapine (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms MULTINEKA
- 15 Sep 2009 Results published in Clinical Infectious Diseases.
- 05 Jun 2007 Status change from in progress to completed.
- 08 Oct 2006 New trial record.